This article has been cited by
1Novel oral anticoagulants in the management of coronary artery disease
Sean R. McMahon,Kathleen Brummel-Ziedins,David J. Schneider
Coronary Artery Disease.2016;27(5)412
[DOI]
2Natural Products for Antithrombosis
Cen Chen,Feng-Qing Yang,Qian Zhang,Feng-Qin Wang,Yuan-Jia Hu,Zhi-Ning Xia
Evidence-Based Complementary and Alternative Medicine.2015;2015(5)1
[DOI]
3Emergency Reversal of Anticoagulation: Novel Agents
Michael Levine,Joshua N. Goldstein
Current Neurology and Neuroscience Reports.2014;14(8)1
[DOI]
4Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence
Vincenzo Russo,Anna Rago,Riccardo Proietti,Federica Di Meo,Andrea Antonio Papa,Paolo Calabrò,Antonio D’Onofrio,Gerardo Nigro,Ahmed AlTurki
Therapeutic Advances in Drug Safety.2017;8(2)67
[DOI]
5Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome
Donal J. Sexton,Declan G. de Freitas,Mark A. Little,Tomas McHugh,Colm Magee,Peter J. Conlon,Conall M. O’Seaghdha
Kidney International Reports.2018;3(4)784
[DOI]
6Effects of Rivaroxaban on Platelet Aggregation
Jesus Hernandez-Juarez,Hugo Guillermo Espejo-Godinez,Rodrigo Mancilla-Padilla,Jose Rubicel Hernandez-Lopez,Jose Antonio Alvarado Moreno,Karim Majluf-Cruz,Manuel Moreno-Hernández,Irma Isordia-Salas,Abraham Majluf-Cruz
Journal of Cardiovascular Pharmacology.2020;75(2)180
[DOI]
7Effects of Rivaroxaban on Platelet Aggregation
Blanca Martinez,Ekaterina Baryshnikova,Maria Lucia Bindi,Domenico Prisco
Journal of Cardiovascular Pharmacology.2016;75(2)173
[DOI]
8Spinal subarachnoid hemorrhage in cortical superficial siderosis after apixaban and clopidogrel therapy
Josef G. Heckmann
Journal of Thrombosis and Thrombolysis.2016;41(4)654
[DOI]
  Feedback 
  Subscribe